Treating Patients With Breast Cancer After Progression on Endocrine Therapy

home / case-based-roundtable-series / treating-patients-with-breast-cancer-after-progression-on-endocrine-therapy

This roundtable series explores therapies after progression on endocrine therapy in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer who have an ESR1 mutation,as discussed by key opinion leaders and participants at virtual live events.